FAK inhibition could also diminish the immunosuppressive MDSCs, TAMs, and Treg, rendering previously unresponsive pancreatic cancer responsive to chemotherapy and immunotherapy [114]. This evidence concerns the gene PTK2 and pancreatic neoplasm.